Sunapten Therapeutics

sunapten therapeutics is a michigan-based, early stage, pharmaceutical company which is developing an innovative approach to stimulating immune responses against tumor antigens and pathological proteins in a wide range of immuno-inflammatory and infectious diseases. the company has filed patents describing proprietary immunological methods of inducing antibody responses against “self” proteins and poorly immunogenic foreign proteins. we use a novel, proprietary and patentable method of making target proteins appear foreign to the immune system and thereby break immune tolerance. sunapten’s novel technology can be applied to proteins on the surface of cancer cells and pathological proteins expressed in numerous disorders including autoimmune and inflammatory diseases. this combines the advantages of small molecule drugs, biologics, and vaccines. platform opportunities the same innovative concept used to produce a prostate cancer vaccine can be applied to other cancer types (renal, breas